# Inceptive

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inceptive

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.inceptive.life
- Total disclosed funding: $100M
- Latest round: Series A (Sep 6, 2023)
- Investors on record: 4

## About

Based in California, US, and founded in 2021 by Jakob Uszkoreit, Inceptive Nucleics, Inc. is a biotechnology company that develops software solutions to help medical professionals to design novel medicines and biotechnologies. In September 2023, Inceptive raised USD 100 million in Series A funding co-led by investors NVIDIA Corporation and Andreessen Horowitz, with participation from Obvious Ventures. As of 2023, the company operates from locations in Palo Alto, US, and Berlin, Germany.



The firm develops an AI (Artificial Intelligence)- powered biological software that helps researchers to design, create and test unique mRNA sequences that help in the development of novel medicines and biotechnologies.

## Funding rounds

- Series A, Sep 6, 2023, $100M — Andreessen Horowitz, Obvious, Section 32, NVentures

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series A
- Obvious (https://capitalatlas.ai/funds/obvious) — Series A
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series A
- NVentures — Series A